Siegel, A. B., Cohen, E. I., Ocean, A., Lehrer, D., Goldenberg, A., Knox, J. J., . . . Schwartz, J. D. (2008). Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. Journal of clinical oncology, 26(18), 2992. https://doi.org/10.1200/JCO.2007.15.9947
Chicago-Zitierstil (17. Ausg.)Siegel, Abby B., et al. "Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma." Journal of Clinical Oncology 26, no. 18 (2008): 2992. https://doi.org/10.1200/JCO.2007.15.9947.
MLA-Zitierstil (9. Ausg.)Siegel, Abby B., et al. "Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma." Journal of Clinical Oncology, vol. 26, no. 18, 2008, p. 2992, https://doi.org/10.1200/JCO.2007.15.9947.